Virax Biolabs (VRAX) Total Liabilities (2021 - 2023)

Virax Biolabs (VRAX) has 3 years of Total Liabilities data on record, last reported at $908401.0 in Q1 2023.

  • For Q1 2023, Total Liabilities fell 27.06% year-over-year to $908401.0; the TTM value through Mar 2023 reached $908401.0, down 27.06%, while the annual FY2023 figure was $908401.0, 27.06% down from the prior year.
  • Total Liabilities reached $908401.0 in Q1 2023 per VRAX's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.2 million in Q1 2022 and bottomed at $871435.0 in Q1 2021.
  • Average Total Liabilities over 3 years is $1.0 million, with a median of $908401.0 recorded in 2023.
  • Peak YoY movement for Total Liabilities: soared 42.92% in 2022, then dropped 27.06% in 2023.
  • A 3-year view of Total Liabilities shows it stood at $871435.0 in 2021, then soared by 42.92% to $1.2 million in 2022, then fell by 27.06% to $908401.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $908401.0 in Q1 2023, $1.2 million in Q1 2022, and $871435.0 in Q1 2021.